Daniel Heller, MD
Pulmonary Disease · Oakland Park, FLNPI 1942508775
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (40.7%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 4 manufacturers reported payments, led by Bard Access Systems, Inc. at 40.7% of the total. Reporting peaked in 2019 at $300 and has fallen 89.3% since, to $32 in 2025. That places this record below the midpoint for pulmonary disease clinicians in FL, where the typical reported total is $2,936.
Across 5 payments — averaging $147.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Access Systems, Inc.$300
- Bard Peripheral Vascular, Inc.$300
- Johnson & Johnson$86
- Cook Medical LLC$51
What the payments were for
- Consulting fees$30041%
- Speaking & faculty fees$30041%
- Food & beverage$13719%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Access Systems, Inc. | 1 | $300 |
| Bard Peripheral Vascular, Inc. | 1 | $300 |
| Johnson & Johnson | 1 | $86 |
| Cook Medical LLC | 2 | $51 |
How this compares
$737 in reported general payments places this provider in the 25th percentile of 953 pulmonary disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium-AlbuterolIpratropium/Albuterol Sulfate | 14 | $416 |
| Furosemide | 13 | $114 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Oakland Park
- Franck RahaghiWeston$1.2M
- Michael OttEglin Afb$909K
- Ali JiwaniOrlando$859K
- Anas HadehWeston$800K
- Jennifer FultonJacksonville$665K
- Ricardo Restrepo-JaramilloTampa$555K
- Mark RumbakTampa$528K
- Jose Soto SotoJacksonville$504K
- Javier Perez FernandezMiami$496K
- Domenick ReinaTampa$469K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.